Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2025 05:00 ET | Source: AiCuris Anti-infective Cures AG

Aicuris Presents Positive Phase 2 Results for Pritelivir and Favorable Phase 1 Safety Data for AIC468 at ID Week 2025

Results from pritelivir Phase 2 study demonstrate a favorable safety profile and a numerically higher lesion healing rate vs. foscarnetPritelivir Phase 2 results supported FDA Breakthrough Therapy...
October 16, 2025 05:00 ET | Source: AiCuris Anti-infective Cures AG

Aicuris Announces Pritelivir Met Primary Endpoint in Immunocompromised Patients with Refractory Herpes Simplex Virus in Phase 3 Pivotal Trial

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments...
September 16, 2025 05:00 ET | Source: AiCuris Anti-infective Cures AG

Aicuris Announces Upcoming Oral and Poster Presentations at ID Week 2025

Company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data overviewUpdated safety and pharmacokinetic results of...
August 05, 2025 05:00 ET | Source: AiCuris Anti-infective Cures AG

Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress

Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in healthy volunteers demonstrated favorable pharmacokinetic (PK)...
July 24, 2025 05:00 ET | Source: AiCuris Anti-infective Cures AG

Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients

Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment...
June 17, 2025 04:21 ET | Source: Research and Markets

$18+ Bn Sexually Transmitted Disease Testing Markets - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2032

Dublin, June 17, 2025 (GLOBE NEWSWIRE) -- The "Sexually Transmitted Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade,...
February 21, 2024 06:07 ET | Source: Transparency Market Research

Oncolytic Virus Immunotherapy Market Expected to Reach USD 572.2 million by 2031, Expanding at a 21.1% CAGR | Transparency Market Research, Inc.

Wilmington, Delaware, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global oncolytic virus immunotherapy market was projected to attain US$ 110.2 million...
July 31, 2023 07:00 ET | Source: Research Nester

Sexually Transmitted Disease Testing Market revenue to exceed USD 145 Billion by 2033, says Research Nester

New York, July 31, 2023 (GLOBE NEWSWIRE) -- The global sexually transmitted disease testing market size is predicted to grow at a CAGR of over ~6% from 2023 to 2035. The market is projected to...
August 10, 2022 08:18 ET | Source: Research and Markets

Global Viral Transport Medium Market Report 2022-2027: Increasing Demand for VTM Due to Surge in Covid-19 Infection & Launch of New Products and Entry of New Market Players

Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "Viral Transport Medium Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global viral...
February 07, 2022 04:18 ET | Source: Research and Markets

Global STD Home Testing Market Report 2021-2027 Featuring AdvaCare Pharma, Biosure, Everlywell, JAL Medical, Mylab Discovery, OraSure Technologies, bioLytical Laboratories, & Autotest

Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "STD Home Testing Market 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global STD home testing market is anticipated to...